United Laboratories International Holdings (STU:UNJ) ROCE %: 1.55% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:UNJ United Laboratories International Holdings Ltd STU:UNJ
65 GF Score
Price €1.00
GF Value €0.93
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is United Laboratories International Holdings ROCE %?

United Laboratories International Holdings STU:UNJ 65 ROCE % is 1.55% as of Dec. 2025. GuruFocus rates STU:UNJ with a GF Score™ of 65/100 and a GF Value™ of €0.93 (Fairly Valued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. United Laboratories International Holdings's annualized ROCE % for the quarter that ended in Dec. 2025 was 1.55%.

United Laboratories International Holdings  (STU:UNJ) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

United Laboratories International Holdings ROCE % Related Terms

United Laboratories International Holdings ROCE % Historical Data

* Premium members only.

The historical data trend for United Laboratories International Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

United Laboratories International Holdings ROCE % Chart

United Laboratories International Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.34 18.99 25.28 21.34 13.23

United Laboratories International Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.94 25.83 17.40 25.51 1.55
STU:UNJ
65GF Score
United Laboratories International Holdings Ltd STU:UNJ
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

United Laboratories International Holdings ROCE % Calculation

United Laboratories International Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=314.973/( ( (3388.488 - 1150.684) + (3746.735 - 1222.114) )/ 2 )
=314.973/( (2237.804+2524.621)/ 2 )
=314.973/2381.2125
=13.23 %

United Laboratories International Holdings's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=38.13/( ( (3554.082 - 1171.902) + (3746.735 - 1222.114) )/ 2 )
=38.13/( ( 2382.18 + 2524.621 )/ 2 )
=38.13/2453.4005
=1.55 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 1.55% mean?
United Laboratories International Holdings (STU:UNJ) has a ROCE % of 1.55% as of Dec. 2025.
Is United Laboratories International Holdings' ROCE % too high?
United Laboratories International Holdings' current ROCE % is 1.55%. The Drug Manufacturers industry median ROCE % is 7.04. United Laboratories International Holdings' value of 1.55% is 78% below this industry median. Overall, United Laboratories International Holdings has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does United Laboratories International Holdings' ROCE % compare to ZTS and UTHR?
United Laboratories International Holdings' ROCE % of 1.55% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.04. United Laboratories International Holdings' value of 1.55% is 78% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. United Laboratories International Holdings's current ROCE % of 1.55% is 78% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. United Laboratories International Holdings's current ROCE % is 1.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is United Laboratories International Holdings stock overvalued right now?
Based on GuruFocus' analysis, United Laboratories International Holdings (STU:UNJ) is currently considered Fairly Valued. The stock's GF Value™ is €0.93, compared to a current price of €1.00 — trading 7% above its estimated fair value. The current ROCE % is 1.55% and 78% below the Drug Manufacturers industry median of 7.04. United Laboratories International Holdings' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For United Laboratories International Holdings (STU:UNJ), the current ROCE % is 1.55% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is United Laboratories International Holdings (STU:UNJ) Overvalued in 2026?

Based on GuruFocus' analysis, United Laboratories International Holdings stock appears to be overvalued. The current stock price of €1.00 is trading 7% above its estimated GF Value™ of €0.93. GuruFocus considers United Laboratories International Holdings to be Fairly Valued.

Key valuation signals for STU:UNJ:

  • ROCE %: 1.55%
  • GF Value™: €0.93 vs. price of €1.00 (7% above fair value)
  • GF Score™: 65/100 with 5 warning signs
  • Industry Position: 78% below the Drug Manufacturers median

No single metric tells the full story. See the STU:UNJ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

United Laboratories International Holdings Business Description

Other Exchanges ULIHF:USA03933:Hong Kong
Address No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
65GF Score

Get the complete analysis for STU:UNJ

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.93
GF Value